AirSculpt Technologies, Inc. (AIRS) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of AirSculpt Technologies, Inc. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIRS
AirSculpt Technologies, Inc.
$1.86HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AIRS vs PYXS
growth of $100 · dividends reinvested · last 5yAIRS -87.4% (-34.0%/yr)PYXS -83.2% (-30.0%/yr)PYXS compounded faster over this window
AIRS PYXS
AIRS vs PYXS: by the numbers
- •AIRS is the larger company ($131M vs $128M market cap).
- •Both run net losses; AIRS's is the smaller (-7.79% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | AIRS | PYXS |
|---|---|---|
| P/S ratio | 0.87 | 11.59 |
| P/B ratio | 1.25 | 11.19 |
| EV / EBITDA | 430.26 | N/A |
| FCF yield | 0.58% | N/A |
Profitability
| Metric | AIRS | PYXS |
|---|---|---|
| Gross margin | 57.63% | 82.77% |
| Operating margin | -7.85% | -609.18% |
| Net margin | -7.79% | -803.83% |
| ROE | -11.20% | -775.59% |
| ROIC | -7.01% | -314.66% |
Growth (annualized)
| Metric | AIRS | PYXS |
|---|---|---|
| Revenue CAGR (5Y) | 8.17% | N/A |
| FCF CAGR (5Y) | -52.36% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.